Alliance for Clinical Trials in Oncology: Prostatic Neoplasms trials

The registry lists 37 Prostatic Neoplasms studies with Alliance for Clinical Trials in Oncology as lead sponsor. 5 are open to participants now and 8 have results posted.

Phase 2 16Phase 3 14No phase 7(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Testing Different Dosing Schedules of the Anti-cancer Drug, Lutetium 177Lu PSMA RLT and Its Effect on Patients With Advanced Prostate Cancer, RECIPROCAL TrialRecruitingNCT07200830Phase 3
• Distance-Based Exercise to Preserve Function and Prevent DisabilityRecruitingNCT07059884Not applicable
• Testing the Addition of Docetaxel (Chemotherapy) to the Usual Treatment (Hormonal Therapy and Apalutamide) for Metastatic Prostate Cancer, ASPIRE TrialRecruitingNCT06931340Phase 3
• Targeted Treatment for Metastatic Prostate Cancer, The PREDICT TrialRecruitingNCT06632977Phase 2
• Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer DetectionRecruitingNCT05334069
• Testing Interruption of Hormonal Medications in Patients Responding Exceptionally to Therapy for Metastatic Prostate Cancer, (A-DREAM)Active, not recruitingNCT05241860Phase 2Results posted
• Decision Aids in Improving Knowledge in Patients With Newly Diagnosed Prostate CancerCompletedNCT03103321Phase 3Results posted
• Enzalutamide With or Without Abiraterone and Prednisone in Treating Patients With Castration-Resistant Metastatic Prostate CancerActive, not recruitingNCT01949337Phase 3Results posted
• Diet in Altering Disease Progression in Patients With Prostate Cancer on Active SurveillanceCompletedNCT01238172Phase 3Results posted
• Surgery With or Without Docetaxel and Leuprolide or Goserelin in Treating Patients With High-Risk Localized Prostate CancerActive, not recruitingNCT00430183Phase 3Results posted
• Stereotactic Radiation Therapy With or Without Whole-Brain Radiation Therapy in Treating Patients With Brain MetastasesCompletedNCT00377156Phase 3Results posted
• Zoledronate in Preventing Skeletal (Bone)-Related Events in Men Who Are Receiving Androgen Deprivation Therapy For Prostate Cancer and Bone MetastasesCompletedNCT00079001Phase 3Results posted
• Chemotherapy, Hormone Therapy, and Radiation Therapy in Treating Patients With Locally Advanced Prostate CancerCompletedNCT00016913Phase 2Results posted
• A Clinical Study Evaluating The Benefit of Adding Rucaparib to Enzalutamide for Men With Metastatic Prostate Cancer That Has Become Resistant To Testosterone-Deprivation TherapyActive, not recruitingNCT04455750Phase 3
• Biomarkers in Bone Marrow and Blood Samples From Patients With Prostate Cancer Treated With KetoconazoleWithdrawnNCT01275651
• Plasma and Urine Samples From Patients With Hormone-Refractory Prostate Cancer Enrolled on Clinical Trials CALGB-9480 or CALGB-9583TerminatedNCT00898833
• Collection of Patient-Reported Symptoms and Performance Status Via the InternetCompletedNCT00417040Not applicable
• Lycopene in Treating Patients With Metastatic Prostate CancerCompletedNCT00068731Phase 2
• Docetaxel, Estramustine, and Exisulind in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone TherapyCompletedNCT00052845Phase 2
• Quality of Life in Patients Undergoing Surgery or Brachytherapy for Stage II Prostate CancerCompletedNCT00052481
• Calcium With or Without Estrogen and/or Risedronate in Preventing Osteoporosis in Patients With Prostate CancerCompletedNCT00043069Phase 3
• Hormone Therapy Followed By Internal Radiation Therapy in Treating Patients With Locally Recurrent Prostate CancerCompletedNCT00032006Phase 2
• Soy Protein Supplement in Preventing Prostate Cancer in Patients With Elevated Prostate-Specific Antigen LevelsCompletedNCT00031746Phase 2
• Gabapentin in Treating Hot Flashes in Patients With Prostate CancerCompletedNCT00028574Phase 3
• Surgery Versus Internal Radiation in Treating Patients With Stage II Prostate CancerCompletedNCT00023686Phase 3
• Androgen Suppression Plus Radiation Therapy in Treating Patients With Prostate CancerCompletedNCT00006359Phase 2
• Flutamide In the Prevention of Prostate Cancer in Patients With Neoplasia of the ProstateCompletedNCT00006214Phase 2
• Green Tea Extract in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone TherapyCompletedNCT00005828Phase 2
• Nitrocamptothecin in Treating Patients With Stage IV Prostate Cancer That Has Not Responded to Hormone TherapyCompletedNCT00005820Phase 2
• Combination Chemotherapy Plus Filgrastim in Treating Patients With Stage IV Prostate Cancer That Has Not Responded to Hormone TherapyCompletedNCT00005810Phase 2
• Mitoxantrone Following Surgery in Treating Patients With Prostate Cancer at High Risk for RecurrenceWithdrawnNCT00003858Phase 2
• Standard Therapy With or Without Dalteparin in Treating Patients With Advanced Breast, Lung, Colorectal, or Prostate CancerCompletedNCT00003674Phase 3
• Hormone Therapy in Treating Patients With Prostate CancerCompletedNCT00003323Phase 2
• Surgery in Treating Patients With Prostate CancerCompletedNCT00002938Phase 2
• Gene Mutations in Patients With Advanced Prostate Cancer That Is Not Responsive to Hormone TherapyCompletedNCT00002924
• Radiation Therapy With Androgen Suppression in Treating Patients With Prostate CancerCompletedNCT00002889Phase 2
• Antiandrogen Withdrawal in Treating Patients With Hormone-Refractory Prostate CancerCompletedNCT00002760Phase 3